Abstract
Pharmacokinetics has proven to be an exceptional tool in pharmaceutical and pharmacologic research. Its development has enhanced the capabilities of providing optimum dosing schedules and formulations for delivery of ethical drugs by relating blood levels of a particular drug to its therapeutic efficacy. Likewise, perturbations in the pharmacokinetic parameters of a compound produced by interactions with a second chemical or with fiver or kidney insufficiency, for example, have provided a more logical basis for the study of drug-drug or drug-chemical interactions, as well as effects of disease states in clinical pharmacology.
Keywords
- Central Compartment
- Elimination Rate Constant
- Peripheral Compartment
- Absorption Rate Constant
- Deep Compartment
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barr WH (1969) Factors involved in the assessment of systemic or biologic availability of drug products. Drug Inf Bull 3:27
Berlin NI, Berman M, Berk PD, Phang JM, Waldmann TA (1968) The application of multicompartmental analysis to problems of clinical medicine, Ann Intern Med 68:423
Cutler DJ (1978) On the definition of the compartment concept in pharmacokinetics. J Theor Biol 73:329
Dost FH (1953) Der Blutspiegel: Kinetic der Konzentrations-aublaute in der Kreislaufflüssigkeit. G Thieme, Leipzig
Dost FH (1958) Klin Wochschr 36:665
Feldman S (1974) Drug distribution, Med Clin North Am 58:917
Garrett ER (1969) Basic concepts and experimental methods of pharmacokinetics. Adv Biosci 5:7
Garrett ER (1970) Clinical significance of pharmacokinetics. In: Dengler HJ (ed) Pharmacological and clinical significance of pharmacokinetics, Symposia in medica Hoechst, F.K. Schaffauer-Verlag, Stuttgart New York pp. 5–21
Garrett ER (1973) Classical pharmacokinetics to the frontier. J Pharmacokinet Biopharm 1:341
Garrett ER, Johnston RL, Collins EJ (1962) Kinetics of steroid effects on Ca47 dynamics in dogs with the analog computer. I. J Pharm Sci 51:1050
Garrett ER, Johnston RL, Collins EJ (1963) Kinetics of steroid effects on Ca47 dynamics in dogs with the analog computer. II. J Pharm Sci 52:668
Garrett ER, Bres J, Schnelle K, Rolf LL Jr (1974) Pharmacokinetics of saturably metabolized amobarbital. J Pharmacokinet Biopharm 2:43
Gibaldi M (1971) Pharmacokinetic aspects of drug metabolism. Ann NY Acad Sei 179:19
Gibaldi M, Feldman S (1969) Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve. J Pharm Sci 58:1477
Gibaldi M, Levy G, Weintraub H (1971) Drug distribution and pharmacologic effects. Clin Pharmacol Ther 12:734
Haley TJ, Young JF (1978) A pharmacokinetic study of pentachlorophenol poisoning and the effects of forced diuresis. Clin Toxicol 12:41
Harris PA, Riegelman S (1969) Influence of the route of administration on the area under the plasma concentration-time curve. J Pharm Sci 58:71
Himmelstein KJ, Lutz RJ (1979) A review of the applications of physiologically based pharmacokinetic modeling. J Pharmacokin et Biopharm 7:127
Holson JF, Kimmel CA, Young JF (1980) The precision of pharmacokinetic parameters for predicting embryotoxicity endpoints. [Abstr] Presented at the 19th Annual Meeting of the Society of Toxicology, Washington DC, March 10, 1950
Houston J, Levy BG (1976) Effect of route of administration on competitive drug biotransformation interaction: salicylamide ascorbic acid interaction in rat. J Pharmacol Exp Ther 198:284
Hull CJ (1979) Symbols for compartmental models. Br J Anaesth 51:815
Jusko WJ (1972) Pharmacodynamic principles in chemical teratology: dose-effect relationships. J Pharmacol Exp Ther 183:469
Kaplan SA, Jack ML, Cotler S, Alexander K (1973) Utilization of area under curve to elucidate the disposition of an extensively biotransformed drug. J Pharmacokinet Biopharm 1:201
Leferink JG, Maes RAA (1979) STRIPACT, an interactive curve fit programme for pharmacokinetic analyses. Arzneim Forsch 29:1894
Levy G (1974 a) Pharmacokinetic control and clinical interpretation of steady-state blood levels of drugs. Clin Pharmacol Ther 16:130
Levy G (1974 b) An orientation to clinical pharmacokinetics. In: Levy G (ed) Clinical pharmacokinetics -a symposium. American Pharmaceutical Association, Academy of Pharmaceutical Sciences, Washington D. C. pp. 1–9
Levy G (1976) Pharmacokinetic approaches to the study of drug interactions. Ann NY Acad Sci 281:24
Levy G, Gibaldi M, Jusko WJ (1969) Multi-compartment pharmacokinetic models and pharmacologic effects. J Pharm Sci 58:422
Niebergall PJ, Sugita ET, Schnaare RL (1974) Calculation of plasma level versus time profiles for variable dosing regimens. J Pharm Sci 63:100
Nogami H, Hanano M, Awazu S, Moon HH (1969) Pharmacokinetic analysis on the disappearance of ethoxybenzamide from plasma. Statistical treatment of data of two compartmental model by a digital computer. Chem Pharm Bull (Tokyo) 17:2097
Nooney GC (1966) Mathematical models in medicine: a diagnosis. J Chronic Dis 19:325
Notari RE (1973) Pharmacokinetics and molecular modification: implications in drug design and evaluation. J Pharm Sci 62:865
Pedersen PV (1977) Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm 5:513
Ramsey JC, Gehring PJ (1980) Application of pharmacokinetic principles in practice. Fed Proc 39:60
Ritschel WA (1970) Biological half-lives of drugs. Drug Intell Clin Pharm 4:332
Runner MN (1967) Comparative pharmacology in relation to teratogenesis. Fed Proc 26:1131
Sedman AJ, Wagner JG (1974a) Quantitative pooling of Michaelis-Menten equations in models with parallel metabolite formation paths. J Pharmacokinet Biopharm 2:149
Sedman AJ, Wagner JG (1974 b) Importance of use of appropriate pharmacokinetic model to analyze in vivo enzyme constants. J Pharmacokinet Biopharm 2:161
Sedman AJ, Wagner JG (1974 c) AUTOAN manual. Publication Distribution Service, Ann Arbor, Michigan
Seman AJ, Wagner JG (1976) CSTRIP, a Fortran IV computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 65:1006
Smyth RD, Hottendorf GH (1980) Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies. Toxicol Appl Pharmacol 53:179–195
Taylor JD, Wiegand RG (1962) The analog computer and plasma drug kinetics. Clin Pharmacol Ther 3:464
Tilstone WJ, Winchester JF, Reavey PC (1979) The use of pharmacokinetic principles in determining the effectiveness of removal of toxins from blood. Clin Pharmacokinet 4:23
Wagner JG (1968 a) Pharmacokinetics. 3. Half-life and volume of distribution. Drug Intell 2:126
Wagner JG (1968 b) Pharmacokinetics. 4. Body water compartments and the distribution of drugs. Drug Intell 2:158
Wagner JG (1971) “Biopharmaceutics and relevant pharmacokinetics.” Drug Intelligence Publications, Hamilton, Illinois
Wagner JG (1973) A modern view of pharmacokinetics. J Pharmacokinet Biopharm 1:363
Wagner JG (1976) Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances. Eur J Clin Pharmacol 20:425
White CG, Young JF, Holson JF (1980) Pharmacokinetic approach to analysis of the “window effect” in teratologic sensitivity [Abstr]. Presented at the 19th Annual Meeting of the Society of Toxicology, Washington, D.C., March 10, 1980
Young JF, Haley TJ (1977) Pharmacokinetic study of a patient intoxicated with 2,4-dichlorophenoxyatic acid and 2-methoxy-3,4-dichlorobenzoic acid. Clin Toxicol 11:489
Young JF, Holson JF (1978) Utility of pharmacokinetics in designing toxicological protocols and improving interspecies extrapolation. J Environ Pathol Toxicol 2:169
Young JF, Kimmel CA, Holson JF (1979) Validation of a pharmacokinetic model for rat embryonal dosimetry of salicylates during a tertogenically susceptible period. Toxicol Appl Pharmacol 48:A21
Zettner A (1973) Principles of competitive binding assays (saturation analyses). I. Equilibrium techniques. Clin Chem 19:699
Zettner A, Duly PE (1974) Principles of competitive binding assays (saturation analyses). II. Sequential saturation. Clin Chem 20:5
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Young, J.F. (1983). Pharmacokinetic Modeling and the Teratologist. In: Johnson, E.M., Kochhar, D.M. (eds) Teratogenesis and Reproductive Toxicology. Handbook of Experimental Pharmacology, vol 65. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81919-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-81919-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81921-6
Online ISBN: 978-3-642-81919-3
eBook Packages: Springer Book Archive